Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 16 | 2022 | 88 | 4.180 |
Why?
|
| Action Potentials | 14 | 2023 | 79 | 3.240 |
Why?
|
| Calcium | 8 | 2023 | 334 | 3.180 |
Why?
|
| Atrial Fibrillation | 4 | 2023 | 79 | 2.140 |
Why?
|
| Heart Atria | 9 | 2023 | 20 | 2.050 |
Why?
|
| Calcium Signaling | 7 | 2022 | 109 | 1.900 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2023 | 12 | 1.610 |
Why?
|
| Rabbits | 10 | 2023 | 178 | 1.470 |
Why?
|
| Calcium Channels, L-Type | 5 | 2019 | 46 | 1.330 |
Why?
|
| Animals | 19 | 2023 | 3330 | 1.250 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2022 | 56 | 1.200 |
Why?
|
| Chloride Channels | 2 | 2016 | 5 | 1.010 |
Why?
|
| Myocardial Contraction | 5 | 2021 | 38 | 0.940 |
Why?
|
| Peptide Hormones | 1 | 2023 | 3 | 0.860 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2023 | 17 | 0.860 |
Why?
|
| Membrane Potentials | 4 | 2022 | 127 | 0.810 |
Why?
|
| Long QT Syndrome | 1 | 2022 | 5 | 0.800 |
Why?
|
| Heart Failure | 1 | 2023 | 118 | 0.770 |
Why?
|
| Gap Junctions | 4 | 2010 | 12 | 0.720 |
Why?
|
| Excitation Contraction Coupling | 2 | 2021 | 10 | 0.630 |
Why?
|
| Sarcoplasmic Reticulum | 5 | 2022 | 155 | 0.590 |
Why?
|
| Connexins | 4 | 2010 | 4 | 0.560 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2017 | 1 | 0.560 |
Why?
|
| Myocardial Ischemia | 1 | 2017 | 29 | 0.540 |
Why?
|
| Heart | 1 | 2017 | 48 | 0.530 |
Why?
|
| Calcium Channels | 1 | 2017 | 96 | 0.520 |
Why?
|
| Chloride Channel Agonists | 1 | 2016 | 1 | 0.520 |
Why?
|
| Patch-Clamp Techniques | 4 | 2017 | 72 | 0.450 |
Why?
|
| Electrocardiography | 1 | 2014 | 81 | 0.450 |
Why?
|
| Cell Membrane Permeability | 2 | 2010 | 47 | 0.410 |
Why?
|
| Quinolinium Compounds | 1 | 2012 | 1 | 0.400 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2012 | 1 | 0.400 |
Why?
|
| 2-Naphthylamine | 1 | 2012 | 3 | 0.400 |
Why?
|
| Body Surface Potential Mapping | 1 | 2012 | 2 | 0.390 |
Why?
|
| Pyridinium Compounds | 1 | 2012 | 5 | 0.390 |
Why?
|
| Heart Conduction System | 1 | 2012 | 6 | 0.390 |
Why?
|
| Heart Ventricles | 3 | 2017 | 71 | 0.370 |
Why?
|
| Sodium-Calcium Exchanger | 2 | 2022 | 9 | 0.360 |
Why?
|
| Molecular Probes | 1 | 2010 | 2 | 0.350 |
Why?
|
| Cyclic AMP | 1 | 2008 | 32 | 0.290 |
Why?
|
| Ion Channel Gating | 1 | 2008 | 114 | 0.270 |
Why?
|
| Potassium Channels | 3 | 2018 | 23 | 0.240 |
Why?
|
| Cell Communication | 3 | 2010 | 24 | 0.240 |
Why?
|
| Angiotensin II | 1 | 2023 | 4 | 0.220 |
Why?
|
| Calmodulin | 1 | 2023 | 7 | 0.220 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2023 | 20 | 0.220 |
Why?
|
| Male | 7 | 2020 | 13669 | 0.210 |
Why?
|
| Calcium, Dietary | 1 | 2023 | 12 | 0.200 |
Why?
|
| Cardiac Conduction System Disease | 1 | 2022 | 1 | 0.200 |
Why?
|
| Apamin | 1 | 2022 | 2 | 0.200 |
Why?
|
| Sodium | 1 | 2022 | 42 | 0.190 |
Why?
|
| Myocardium | 1 | 2022 | 94 | 0.180 |
Why?
|
| Cells, Cultured | 4 | 2019 | 492 | 0.180 |
Why?
|
| Connexin 26 | 3 | 2010 | 3 | 0.180 |
Why?
|
| Atrial Function | 1 | 2021 | 2 | 0.180 |
Why?
|
| Maf Transcription Factors, Large | 1 | 2020 | 2 | 0.160 |
Why?
|
| Heart Rate | 1 | 2020 | 94 | 0.160 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 16 | 0.160 |
Why?
|
| Insulin-Secreting Cells | 1 | 2020 | 11 | 0.160 |
Why?
|
| Muscle Proteins | 1 | 2020 | 25 | 0.160 |
Why?
|
| Connexin 43 | 2 | 2010 | 6 | 0.160 |
Why?
|
| Uncoupling Agents | 1 | 2019 | 4 | 0.160 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2019 | 6 | 0.160 |
Why?
|
| beta Catenin | 1 | 2020 | 58 | 0.160 |
Why?
|
| Adrenergic beta-Agonists | 3 | 2019 | 15 | 0.150 |
Why?
|
| Humans | 12 | 2021 | 24703 | 0.150 |
Why?
|
| HeLa Cells | 4 | 2010 | 37 | 0.140 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2017 | 2 | 0.140 |
Why?
|
| Rana esculenta | 1 | 2017 | 2 | 0.140 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 21 | 0.140 |
Why?
|
| Stress, Physiological | 1 | 2017 | 15 | 0.140 |
Why?
|
| Muscle Cells | 1 | 2017 | 12 | 0.140 |
Why?
|
| Isoproterenol | 1 | 2017 | 13 | 0.140 |
Why?
|
| Mitochondria | 1 | 2017 | 56 | 0.140 |
Why?
|
| Intracellular Space | 1 | 2017 | 5 | 0.130 |
Why?
|
| Kinetics | 1 | 2017 | 149 | 0.130 |
Why?
|
| Models, Biological | 1 | 2017 | 284 | 0.120 |
Why?
|
| Albuterol | 2 | 2005 | 11 | 0.120 |
Why?
|
| Ion Transport | 1 | 2014 | 22 | 0.120 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2014 | 12 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2014 | 40 | 0.120 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2014 | 134 | 0.110 |
Why?
|
| Anions | 2 | 2010 | 4 | 0.100 |
Why?
|
| Cations | 2 | 2010 | 11 | 0.100 |
Why?
|
| Fluorescent Dyes | 1 | 2012 | 31 | 0.100 |
Why?
|
| Swine | 1 | 2012 | 63 | 0.100 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 2 | 2009 | 11 | 0.090 |
Why?
|
| Tissue Culture Techniques | 1 | 2011 | 7 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 437 | 0.090 |
Why?
|
| Light | 1 | 2011 | 55 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2010 | 59 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 598 | 0.080 |
Why?
|
| Biological Clocks | 1 | 2009 | 12 | 0.080 |
Why?
|
| Ion Channels | 1 | 2009 | 118 | 0.080 |
Why?
|
| Kidney | 1 | 2009 | 139 | 0.070 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2008 | 4 | 0.070 |
Why?
|
| Genes, Reporter | 1 | 2008 | 20 | 0.070 |
Why?
|
| Diffusion | 1 | 2008 | 22 | 0.070 |
Why?
|
| Eye Proteins | 1 | 2008 | 6 | 0.070 |
Why?
|
| Electric Conductivity | 1 | 2008 | 53 | 0.070 |
Why?
|
| Point Mutation | 1 | 2008 | 24 | 0.070 |
Why?
|
| Cataract | 1 | 2008 | 19 | 0.070 |
Why?
|
| Permeability | 1 | 2008 | 88 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 228 | 0.070 |
Why?
|
| Rats, Wistar | 2 | 2019 | 44 | 0.060 |
Why?
|
| Dogs | 2 | 2020 | 147 | 0.060 |
Why?
|
| Diuretics, Osmotic | 1 | 2005 | 3 | 0.060 |
Why?
|
| Mannitol | 1 | 2005 | 11 | 0.060 |
Why?
|
| Rats | 2 | 2019 | 609 | 0.050 |
Why?
|
| Time Factors | 2 | 2020 | 1327 | 0.040 |
Why?
|
| Diastole | 1 | 2020 | 23 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2020 | 14 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2020 | 3 | 0.040 |
Why?
|
| Protein Stability | 1 | 2020 | 5 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2020 | 19 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 39 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 49 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2020 | 45 | 0.040 |
Why?
|
| Insulin | 1 | 2020 | 82 | 0.040 |
Why?
|
| Proton Ionophores | 1 | 2019 | 1 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2020 | 167 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 210 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2020 | 174 | 0.040 |
Why?
|
| Gene Expression | 1 | 2020 | 196 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2020 | 290 | 0.040 |
Why?
|
| Phenotype | 1 | 2020 | 280 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2020 | 159 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 398 | 0.040 |
Why?
|
| Electrophysiology | 2 | 2008 | 71 | 0.040 |
Why?
|
| Transfection | 2 | 2008 | 115 | 0.030 |
Why?
|
| Mice | 1 | 2020 | 1296 | 0.030 |
Why?
|
| Osmotic Pressure | 2 | 2005 | 5 | 0.030 |
Why?
|
| Female | 2 | 2020 | 14048 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2011 | 1 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 13 | 0.020 |
Why?
|
| Biotin | 1 | 2008 | 7 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2008 | 6 | 0.020 |
Why?
|
| Isoquinolines | 1 | 2008 | 11 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 15 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 21 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 52 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 70 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 113 | 0.020 |
Why?
|
| Connexin 30 | 1 | 2007 | 1 | 0.020 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2007 | 1 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2007 | 2 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2007 | 5 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 21 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2007 | 32 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 256 | 0.020 |
Why?
|
| Osmosis | 1 | 2005 | 5 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2005 | 16 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 314 | 0.010 |
Why?
|
| Adult | 1 | 2005 | 7255 | 0.010 |
Why?
|
| Middle Aged | 1 | 2005 | 8294 | 0.010 |
Why?
|
| Aged | 1 | 2005 | 8382 | 0.010 |
Why?
|